GGrantIndex
Sort

261,768 grants matching gene therapy

Atrial Fibrillation Post-GWAS: Mechanisms to Treatment

$2,841,649
Mina Kay Chung · Cleveland Clinic Lerner Com-Cwru · P01 · FY2022 · HL

Atrial Fibrillation Post-GWAS: Mechanisms to Treatment

$2,841,649
Mina Kay Chung · Cleveland Clinic Lerner Com-Cwru · P01 · FY2025 · HL

Impact of CAR and Nrf2 dual activation on cyclophosphamide bioactivation and doxorubicin detoxification

$2,840,768
Hongbing Wang · University Of Maryland Baltimore · R01 · FY2025 · CA

Immunobiology for Marrow Allografts for Leukemia

$2,840,400
Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2014 · CA

THE PHARMACOGENETICS OF ASTHMA TREATMENT

$2,840,148
Brigham And Women'S Hospital · U01 · FY2003 · HL

Understanding Papillomavirus Virion Proteins and Vaccines

$2,839,931
John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Genetic and Biochemical Approaches to Tyrosine Kinase and Lymphocyte Signaling

$2,838,737
Pamela Schwartzberg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

PHARMACOGENOMICS OF ARRHYTHMIA THERAPY

$2,836,953
Vanderbilt University · U01 · FY2004 · HL

Pharmacogenomics of Statin Therapy

$2,836,708
Ronald M Krauss · Children'S Hospital & Res Ctr At Oakland · P50 · FY2015 · GM

Structural Biology of Genome Maintenance and DNA repair

$2,836,536
Scott Williams · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES

CURE SICKLE CELL INITIATIVE DATA STRATEGY AND DATA RESOURCES PROGRAM

$2,836,378
Barbara L Kroner · Research Triangle Institute · OT3 · FY2024 · HL

Disease mechanism and therapies for retinal degeneration

$2,835,536
Tiansen Li · National Eye Institute · ZIA · FY2022 · EY

Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC)

$2,835,251
Merit E Cudkowicz · Massachusetts General Hospital · U01 · FY2023 · NS

SAN ANTONIO CANCER INSTITUTE

$2,834,018
University Of Texas Hlth Sci Ctr San Ant · P30 · FY2004 · CA

Metabolic Regulation by SAPS3 of Virus-specific T cell Immunity

$2,832,747
Roberto Tinoco · University Of California-Irvine · R01 · FY2025 · AI

University of Washington Sexually Transmitted Infections Cooperative Research Cen

$2,832,119
Anna Wald · University Of Washington · U19 · FY2016 · AI

Vanderbilt Proteome Characterization Center

$2,832,105
Daniel C Liebler · Vanderbilt University · U24 · FY2012 · CA

Understanding Down Syndrome as an Interferonopathy

$2,830,725
Joaquin M. Espinosa · University Of Colorado Denver · R01 · FY2019 · AI

Clinical Genomics and Experimental Therapeutics

$2,830,248
Falk Lohoff · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2020 · AA

Communication Bridge: Optimizing an evidence-based intervention for individuals with primary progressive aphasia

$2,829,449
Emily J Rogalski · University Of Chicago · R01 · FY2024 · AG

HCMR Novel Markers of Prognosis in Hypertrophic Cardiomyopathy

$2,829,326
Christopher M Kramer · University Of Virginia · U01 · FY2016 · HL

Muscle Disease Unit

$2,828,476
Andrew Mammen · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2025 · AR

Stem Cell Transplantation: Basic/Clinical Research

$2,827,583
Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2009 · HL

Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication

$2,826,477
Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2022 · AI

The Genetics of the Neuromuscular Junction: Mechanisms and Disease Models

$2,825,120
Robert W Burgess · Jackson Laboratory · R37 · FY2020 · NS